BLISSGVS.BO
BLISSGVS.BO
INE416D01022
BLISS GVS PHARMA LTD.
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2026 2025 Change %
Total Revenue 9.206.389.000 8.017.955.000
14.8%
Cost of Revenue 4.250.645.000 4.136.882.000
2.7%
Gross Profit 4.955.744.000 3.881.073.000
27.7%
3.364.870.000 2.903.496.000
15.9%
Operating Income 1.590.874.000 977.577.000
62.7%
Pretax Income 1.895.892.000 1.256.392.000
50.9%
Net Income Common Stockholders 1.291.292.000 842.993.000
53.2%
-- --
--
-- --
--
ende